Shiseido Granted Patent for Skin Composition Formulations and Methods
Summary
USPTO granted Patent US12599623B2 to Shiseido Company, Limited on April 14, 2026. The patent covers body corrective cosmetic formulations and methods of use thereof, including skin treatment compositions. The application was filed on June 29, 2017 under Application No. 15638059 with 13 claims.
What changed
USPTO granted Patent US12599623B2 to Shiseido Company, Limited, covering body corrective cosmetic formulations and methods of use. The patent includes 13 claims and multiple CPC classifications related to skin treatment compositions and methods.
The grant provides Shiseido exclusive rights to the patented formulations and methods, which may impact competitors developing similar cosmetic products. Manufacturers and investors in the cosmetics sector should review the patent scope to assess potential licensing needs or design-around considerations.
Archived snapshot
Apr 19, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Skin compositions and methods of use thereof
Grant US12599623B2 Kind: B2 Apr 14, 2026
Assignee
Shiseido Company, Limited
Inventors
Betty Yu, Joseph Lomakin, Soo-Young Kang, Benjamin W. Adams
Abstract
Provided are body corrective cosmetic formulations and methods of use thereof.
CPC Classifications
A61K 8/19 A61K 8/25 A61K 8/29 A61K 8/0204 A61K 8/345 A61K 8/585 A61K 31/765 A61K 8/891 A61K 8/894 A61K 8/895 A61K 2800/43 A61K 2800/58 A61K 2800/95 A61K 2800/412 A61K 2800/884 A61K 2800/5922 A61L 26/0019 A61L 26/0095 A61P 17/00 A61P 17/02 A61Q 1/14 A61Q 19/00 A61Q 1/02 A61Q 19/06 A61Q 19/08 C08L 83/04
Filing Date
2017-06-29
Application No.
15638059
Claims
13
Related changes
Get daily alerts for USPTO Patent Grants - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.